This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

Relationship: 2844

Title

A descriptive phrase which clearly defines the two KEs being considered and the sequential relationship between them (i.e., which is upstream, and which is downstream). More help

Altered Bone Cell Homeostasis leads to Bone Remodeling

Upstream event
The causing Key Event (KE) in a Key Event Relationship (KER). More help
Downstream event
The responding Key Event (KE) in a Key Event Relationship (KER). More help

Key Event Relationship Overview

The utility of AOPs for regulatory application is defined, to a large extent, by the confidence and precision with which they facilitate extrapolation of data measured at low levels of biological organisation to predicted outcomes at higher levels of organisation and the extent to which they can link biological effect measurements to their specific causes.Within the AOP framework, the predictive relationships that facilitate extrapolation are represented by the KERs. Consequently, the overall WoE for an AOP is a reflection in part, of the level of confidence in the underlying series of KERs it encompasses. Therefore, describing the KERs in an AOP involves assembling and organising the types of information and evidence that defines the scientific basis for inferring the probable change in, or state of, a downstream KE from the known or measured state of an upstream KE. More help

AOPs Referencing Relationship

AOP Name Adjacency Weight of Evidence Quantitative Understanding Point of Contact Author Status OECD Status
Deposition of energy leading to occurrence of bone loss adjacent Moderate Low Cataia Ives (send email) Open for citation & comment

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) that help to define the biological applicability domain of the KER.In general, this will be dictated by the more restrictive of the two KEs being linked together by the KER.  More help
Term Scientific Term Evidence Link
human Homo sapiens Low NCBI
mouse Mus musculus High NCBI
rat Rattus norvegicus High NCBI

Sex Applicability

An indication of the the relevant sex for this KER. More help
Sex Evidence
Male High
Female Moderate
Unspecific Low

Life Stage Applicability

An indication of the the relevant life stage(s) for this KER.  More help
Term Evidence
Adult High
Juvenile Moderate

Key Event Relationship Description

Provides a concise overview of the information given below as well as addressing details that aren’t inherent in the description of the KEs themselves. More help

The bone microenvironment is defined as a complex structural and biological system containing mesenchymal cells from different lineages; bone resident cells, such as osteoclasts, osteoblasts, and osteocytes; and the bone extracellular matrix. For bone structure to remain at a homeostatic level, osteoclasts and osteoblasts must act in unison so that bone resorption does not outpace bone formation, and vice versa. Osteoblasts differentiate from mesenchymal stem cells (MSCs) into pre-osteoblasts, then pre-osteoblasts migrate to the site of bone resorption where they become fully functioning osteoblasts capable of depositing new bone matrix (Donaubauer et al., 2020). Osteoclasts originate from hematopoietic stem cells (HSCs) in the bone marrow and their differentiation into pre-osteoclasts is stimulated by the release of cytokines by osteocytes, osteoblasts, and immune cells (Donauabauer et al., 2020). Imbalances in the regulation of osteoblast and osteoclast differentiation and proliferation results in altered bone cell homeostasis and consequent disruption to bone remodeling (Chatziravdeli et al., 2019; Donaubauer et al., 2020; Smith, 2020a; Smith, 2020b; Tian et al., 2017). 

Altered bone cell homeostasis can be defined by an increase in osteoclast number and activity and a decrease in osteoblast number and activity, resulting in an imbalance in bone formation and resorption. Altered cell processes can increase osteoclast activity and decrease osteoblast activity and the production of the organic and inorganic components of the bone matrix. As a result of altered bone cell homeostasis, bone remodeling processes may be impacted. Each remodeling event, known as a basic multicellular unit (BMU), consists of osteoclasts, bone resorption cells, osteoblasts, and bone-forming cells (Raggatt & Partridge; Slyfield et al., 2012, Frost, 1966). The BMU activity can be assessed by examining parameters of dynamic bone histomorphometry. The structural model index (SMI) of bone tissue, which measures the proportion of rods and plates in trabecular bone, also serves as an important marker of bone structural changes (Shahnazari et al., 2012). A disruption in the activity of bone remodeling cells, such as bone MSCs, osteoblasts and osteoclasts, leads to dysfunction of bone cells and downstream altered bone remodeling (Wright et al., 2015; Zhang et al., 2018). The strict regulation of differentiation pathways that define osteoblast/osteoclastogenesis is essential for the maintenance of osteogenic balance and functioning of bone cells to bone remodeling.

Evidence Collection Strategy

Include a description of the approach for identification and assembly of the evidence base for the KER. For evidence identification, include, for example, a description of the sources and dates of information consulted including expert knowledge, databases searched and associated search terms/strings.  Include also a description of study screening criteria and methodology, study quality assessment considerations, the data extraction strategy and links to any repositories/databases of relevant references.Tabular summaries and links to relevant supporting documentation are encouraged, wherever possible. More help

The strategy for collating the evidence on radiation stressors to support the relationship is described in Kozbenko et al 2022. Briefly, a scoping review methodology was used to prioritize studies based on a population, exposure, outcome, endpoint statement.

Evidence Map 2.0

ID Experimental Design Species Upstream Observation Downstream Observation Citation (first author, year) Notes

Evidence Map

Addresses the scientific evidence supporting KERs in an AOP setting the stage for overall assessment of the AOP. More help
Title First Author
Biological Plausibility
Dose Concordance
Temporal Concordance
Incidence Concordance
Biological Plausibility
Dose Concordance Evidence
Temporal Concordance Evidence
Incidence Concordance Evidence
Uncertainties and Inconsistencies
Addresses inconsistencies or uncertainties in the relationship including the identification of experimental details that may explain apparent deviations from the expected patterns of concordance. More help

None identified

Known modulating factors

This table captures specific information on the MF, its properties, how it affects the KER and respective references.1.) What is the modulating factor? Name the factor for which solid evidence exists that it influences this KER. Examples: age, sex, genotype, diet 2.) Details of this modulating factor. Specify which features of this MF are relevant for this KER. Examples: a specific age range or a specific biological age (defined by...); a specific gene mutation or variant, a specific nutrient (deficit or surplus); a sex-specific homone; a certain threshold value (e.g. serum levels of a chemical above...) 3.) Description of how this modulating factor affects this KER. Describe the provable modification of the KER (also quantitatively, if known). Examples: increase or decrease of the magnitude of effect (by a factor of...); change of the time-course of the effect (onset delay by...); alteration of the probability of the effect; increase or decrease of the sensitivity of the downstream effect (by a factor of...) 4.) Provision of supporting scientific evidence for an effect of this MF on this KER. Give a list of references.  More help

Modulating Factors

Details

Effects on the KER

References

Drug 

Sclerostin (Wnt antagonist) suppression

Sclerostin, a Wnt antagonist, expression in adults is primarily restricted to osteocytes. The suppression of sclerostin was examined using Scl-Ab. Scl-Ab was found to completely reverse the effects of radiation on bone tissue. Scl-Ab injections not only blocked any structural deterioration, but also increased bone mass and improved bone quality in the radiated area to the same levels as in a non-radiated area with Scl-Ab treatment. 

Chandra et al., 2017 

Drug  

Parathyroid hormone (PTH)1-34

Rats were given daily injections of human recombinant PTH (PTH1-34) to avoid the effects of ionizing radiation after being exposed to 16 Gy of X-rays. Compared to the irradiated group, rats treated with PTH1-34 had a 70.6% decrease in apoptotic osteoblasts (from 34 percent to 10 percent) and a 53% decrease in apoptosis in osteocytes.  

Chandra et al., 2014 

Age 

Old age

Lower estrogen at old age is thought to contribute to higher osteoclast activity and increased bone resorption.

Pacheco and Stock, 2013

Domain of Applicability

A free-text section of the KER description that the developers can use to explain their rationale for the taxonomic, life stage, or sex applicability structured terms. More help

Considerable evidence is available in mice and rats. The relationship has been demonstrated in vivo for both males and females, with more available evidence for males. In vivo evidence is derived from adolescents and adult models, with considerable evidence for adults.